The Role of Helicobacter Pylori in Pancreatico-Biliary Disease

被引:0
|
作者
Yi, Sun Young [1 ]
机构
[1] Ewha Womans Univ, Coll Med, Dept Internal Med, Seoul, South Korea
来源
EWHA MEDICAL JOURNAL | 2006年 / 29卷 / 01期
关键词
Helicobacter pylori; Bile; Pancreatic cancer; Biliary tract carcinoma; Gallstone;
D O I
10.12771/emj.2006.29.1.17
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective : The role of Helicobacter pylori (Hp) in benign and malignant pancreatico-biliary tract disease is concerned in recent papers. The urease gene of Hp were found in human bile, and bacteria morphologically resembling Hp were found in resected gallbladder mucosa from patients with gallbladder disease. It was hypothesized that there is an association between the presence of Hp in bile and pancreatico-biliary disease. The aims of this study are to examine if Hp exist in the bile juice and to investigate whether Hp plays a role in the pancreatico-biliary disease. Methods : Thirty-eight patients (18 males and 20 females, mean age 71 +/- 27yr; range 45-92 yr) with gallstone and malignant pancreatico-biliary disease were enrolled in this study; 23 cases were gallstone diseases, 10 cases were cholangiocarcinomas, and 5 cases were pancreatic cancers. Thirty-eight controls were age-and sex-matched and enrolled from subject attending routine medical check-up. The presence of Hp in stomach was confirmed by C-14-breath test. The polymerase chain reaction (PCR) assay was used to detect the Hp in bile. Results : The Hp-positive rate in stomach was much higher in control (26/38, 68.4%) than the patients with pancreatico-biliary disease (11/38, 28.9%) (p <0.01). The Hp-positive rate in bile of pancreatico-biliary disease was 18.4% but, there is no relation between of the presence of Hp in the stomach and in the bile (p=0.33). Also there was no significant difference of the presence of Hp in bile (p>0.05) and stomach (p=0.28) between benign and malignant disease. Conclusion : The Hp-positive rate in bile was similar in benign and malignant pancreaticobiliary disease. But Hp may not be important risk factor in pancreatico-biliary disease in Hp prevalent country like south Korea.
引用
收藏
页码:19 / 23
页数:5
相关论文
共 50 条
  • [11] ANOMALOUS JUNCTION OF THE PANCREATICO-BILIARY SYSTEM
    HABER, GB
    KORTAN, PP
    COHEN, LB
    MARCON, NE
    GASTROINTESTINAL ENDOSCOPY, 1985, 31 (02) : 167 - 168
  • [12] Effect of PYY on pancreatico-biliary secretion
    Symersky, T
    Frolich, M
    Biemond, I
    Masclee, A
    GASTROENTEROLOGY, 2004, 126 (04) : A62 - A62
  • [13] ANTRAL CONTROL OF PANCREATICO-BILIARY FUNCTION
    DEBAS, HT
    YAMAGISHI, T
    GASTROENTEROLOGY, 1977, 72 (05) : 1045 - 1045
  • [14] ANOMALOUS JUNCTION OF THE PANCREATICO-BILIARY SYSTEM
    HABER, GB
    KORTAN, PP
    COHEN, LB
    MARCON, NE
    HEPATOLOGY, 1985, 5 (05) : 997 - 997
  • [15] Pancreatico-Biliary Stricture by Benign Hepatic Cysts
    Kim, Hyaehwan
    Beck, Gregory
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S715 - S716
  • [16] ENDOSCOPIC PALLIATIVE THERAPY FOR PANCREATICO-BILIARY CARCINOMA
    DELMOTTE, JS
    LIGUORY, C
    REY, JF
    SAHEL, J
    CORTOT, A
    PARIS, JC
    GASTROENTEROLOGY, 1984, 86 (05) : 1060 - 1060
  • [17] Pancreatico-biliary malignancy: Prevalence and risk factors
    Lowenfels, AB
    Maisonneuve, P
    ANNALS OF ONCOLOGY, 1999, 10 : 1 - 3
  • [18] Role of ERCP in patients with pancreatico-biliary (PB) disease in the setting of hematopoietic stem cell transplant (HSCT)
    Al Nusair, M
    de Magalhaes-Silverman, MC
    Silverman, WB
    GASTROINTESTINAL ENDOSCOPY, 2005, 61 (05) : AB197 - AB197
  • [19] AGGRESSIVE PALLIATION FOR INOPERABLE PANCREATICO-BILIARY CANCER
    KALFOPOULOS, P
    PETROPOULOS, P
    HADJI, M
    HAHNLOSER, P
    HELVETICA CHIRURGICA ACTA, 1982, 49 (1-2) : 151 - 153
  • [20] Biliary reflux detection in anomalous union of the pancreatico-biliary duct patients
    Yeom, Suk Keu
    Lee, Seung Wha
    Cha, Sang Hoon
    Chung, Hwan Hoon
    Je, Bo Kyung
    Kim, Baek Hyun
    Hyun, Jong Jin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (09) : 952 - 959